Glad I didn't throw money at it but it sure was a very promising announcement.... could easily rebound and I'll be watching for a possible turnaround after the tree has been shaken.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%